 GLP-1 Receptor Agonist Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026-2033
Persistence Market Research has recently released a comprehensive report on the global GLP-1 Receptor Agonist market. The report delivers an in-depth evaluation of key market dynamics-drivers, tren... もっと見る
英語原文をAIを使って翻訳しています。
SummaryPersistence Market Research has recently released a comprehensive report on the global GLP-1 Receptor Agonist market. The report delivers an in-depth evaluation of key market dynamics-drivers, trends, opportunities, and restraints-while offering detailed insights into market structure, value chain evolution, and competitive positioning across regions.Key Insights ・GLP-1 Receptor Agonist Market Size (2026E): US$ 74.4 Bn ・Projected Market Value (2033F): US$ 232.8 Bn ・Global Market Growth Rate (CAGR 2026-2033): 17.7% GLP-1 Receptor Agonist Market - Report Scope The glp-1 receptor agonist market encompasses the ecosystem of manufacturers, suppliers, and end-users engaged in the production, distribution, and application of glp-1 receptor agonist products and solutions. The market serves a wide range of end-use industries, and rapid technological advancements alongside evolving end-user requirements are significantly influencing market expansion across major global regions. Market Growth Drivers Strong clinical outcomes showing GLP-1 therapies deliver significant body weight reduction and HbA1c improvement in diabetic patients. Market Restraints High therapy costs create substantial financial barriers limiting patient access without insurance coverage. Market Opportunities Expanding global obesity prevalence presents significant growth potential for GLP-1 therapies. Key Questions Answered in the Report ・What are the major factors driving global demand for glp-1 receptor agonist? ・Which product and indication segments are witnessing the highest growth in the glp-1 receptor agonist market? ・How is the competitive landscape evolving in the glp-1 receptor agonist market? ・Who are the leading players in the glp-1 receptor agonist market, and what strategies are they adopting? ・What are the emerging trends and long-term growth prospects for the global glp-1 receptor agonist market? Competitive Intelligence and Business Strategy Leading players in the glp-1 receptor agonist market are focusing on capacity expansion, product innovation, and strategic partnerships to strengthen their global footprint. Companies are investing in R&D and sustainable practices while pursuing collaborations, mergers, and regional expansion to gain a competitive edge. Key Companies Profiled ・Eli Lilly and Company ・Novo-Nordisk A/S ・Sanofi ・AstraZeneca ・Amgen, Inc. ・Innovent Biologics, Inc. Market Segmentation By Product ・Ozempic ・Wegovy ・Rybelsus ・Victoza ・Zepbound ・Saxenda ・Trulicity ・Mounjaro By Indication ・Type 2 Diabetes mellitus ・Obesity By Region ・North America ・Europe ・East Asia ・South Asia & Oceania ・Middle East & Africa ・Latin America Table of Contents1. Executive Summary1.1. Global GLP-1 Receptor Agonist Market Snapshot, 2026 and 2033 1.2. Market Opportunity Assessment, 2026-2033, US$ Mn 1.3. Key Market Trends 1.4. Future Market Projections 1.5. Premium Market Insights 1.6. Industry Developments and Key Market Events 1.7. PMR Analysis and Recommendations 2. Market Overview 2.1. Market Scope and Definition 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Opportunity 2.2.4. Challenges 2.2.5. Key Trends 2.3. Product Lifecycle Analysis 2.4. GLP-1 Receptor Agonist Market: Value Chain 2.4.1. List of Raw Material Suppliers 2.4.2. List of Manufacturers 2.4.3. List of Distributors 2.4.4. Profitability Analysis 2.5. Forecast Factors - Relevance and Impact 2.6. Covid-19 Impact Assessment 2.7. PESTLE Analysis 2.8. Porter Five Force's Analysis 2.9. Geopolitical Tensions: Market Impact 2.10. Regulatory and Application Landscape 3. Macro-Economic Factors 3.1. Global Sectorial Outlook 3.2. Global GDP Growth Outlook 3.3. Global Parent Market Overview 4. Price Trend Analysis, 2019-2033 4.1. Key Highlights 4.2. Key Factors Impacting Product Prices 4.3. Prices By Product Type/Composition/Application 4.4. Regional Prices and Product Preferences 5. Global GLP-1 Receptor Agonist Market Outlook: Historical (2019-2025) and Forecast (2026-2033) 5.1. Key Highlights 5.1.1. Market Size and Y-o-Y Growth 5.1.2. Absolute $ Opportunity 5.2. Market Size (US$ Mn) Analysis and Forecast 5.2.1. Historical Market Size Analysis, 2019-2025 5.2.2. Current Market Size Forecast, 2026-2033 5.3. Global GLP-1 Receptor Agonist Market Outlook: Product 5.3.1. Introduction / Key Findings 5.3.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2025 5.3.3. Current Market Size (US$ Mn) Forecast By Product, 2026-2033 5.3.3.1. Ozempic 5.3.3.2. Wegovy 5.3.3.3. Rybelsus 5.3.3.4. Victoza 5.3.3.5. Zepbound 5.3.3.6. Saxenda 5.3.3.7. Trulicity 5.3.3.8. Mounjaro 5.4. Market Attractiveness Analysis: Product 5.5. Global GLP-1 Receptor Agonist Market Outlook: Indication 5.5.1. Introduction / Key Findings 5.5.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2025 5.5.3. Current Market Size (US$ Mn) Forecast By Indication, 2026-2033 5.5.3.1. Type 2 Diabetes mellitus 5.5.3.2. Obesity 5.6. Market Attractiveness Analysis: Indication 6. Global GLP-1 Receptor Agonist Market Outlook: Region 6.1. Key Highlights 6.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2025 6.3. Current Market Size (US$ Mn) Forecast By Region, 2026-2033 6.3.1. North America 6.3.2. Europe 6.3.3. East Asia 6.3.4. South Asia and Oceania 6.3.5. Latin America 6.3.6. Middle East & Africa 6.4. Market Attractiveness Analysis: Region 7. North America GLP-1 Receptor Agonist Market Outlook: Historical (2019-2025) and Forecast (2026-2033) 7.1. Key Highlights 7.2. Pricing Analysis 7.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025 7.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033 7.4.1. By Product 7.4.2. By Indication 7.4.3. By Country: U.S. and Canada 7.5. Market Attractiveness Analysis 8. Europe GLP-1 Receptor Agonist Market Outlook: Historical (2019-2025) and Forecast (2026-2033) 8.1. Key Highlights 8.2. Pricing Analysis 8.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025 8.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033 8.4.1. By Product 8.4.2. By Indication 8.4.3. By Country: Germany, Italy, France, U.K., Spain, Russia, Rest of Europe 8.5. Market Attractiveness Analysis 9. East Asia GLP-1 Receptor Agonist Market Outlook: Historical (2019-2025) and Forecast (2026-2033) 9.1. Key Highlights 9.2. Pricing Analysis 9.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025 9.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033 9.4.1. By Product 9.4.2. By Indication 9.4.3. By Country: China, Japan, South Korea 9.5. Market Attractiveness Analysis 10. South Asia and Oceania GLP-1 Receptor Agonist Market Outlook: Historical (2019-2025) and Forecast (2026-2033) 10.1. Key Highlights 10.2. Pricing Analysis 10.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025 10.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033 10.4.1. By Product 10.4.2. By Indication 10.4.3. By Country: India, ASEAN, Oceania, Rest of South Asia 10.5. Market Attractiveness Analysis 11. Latin America GLP-1 Receptor Agonist Market Outlook: Historical (2019-2025) and Forecast (2026-2033) 11.1. Key Highlights 11.2. Pricing Analysis 11.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025 11.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033 11.4.1. By Product 11.4.2. By Indication 11.4.3. By Country: Brazil, Mexico, Rest of Latin America 11.5. Market Attractiveness Analysis 12. Middle East & Africa GLP-1 Receptor Agonist Market Outlook: Historical (2019-2025) and Forecast (2026-2033) 12.1. Key Highlights 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025 12.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033 12.4.1. By Product 12.4.2. By Indication 12.4.3. By Country: GCC Countries, South Africa, Rest of Middle East & Africa 12.5. Market Attractiveness Analysis 13. Competitive Landscape 13.1. Market Share Analysis by Company, 2026 13.2. Competitive Dashboard 13.3. Company Profiles 13.3.1. Eli Lilly and Company 13.3.1.1. Company Overview 13.3.1.2. Product Portfolio 13.3.1.3. Financial Overview 13.3.1.4. Business Strategies and Developments 13.3.2. Novo-Nordisk A/S 13.3.2.1. Company Overview 13.3.2.2. Product Portfolio 13.3.2.3. Financial Overview 13.3.2.4. Business Strategies and Developments 13.3.3. Sanofi 13.3.3.1. Company Overview 13.3.3.2. Product Portfolio 13.3.3.3. Financial Overview 13.3.3.4. Business Strategies and Developments 13.3.4. AstraZeneca 13.3.4.1. Company Overview 13.3.4.2. Product Portfolio 13.3.4.3. Financial Overview 13.3.4.4. Business Strategies and Developments 13.3.5. Amgen, Inc. 13.3.5.1. Company Overview 13.3.5.2. Product Portfolio 13.3.5.3. Financial Overview 13.3.5.4. Business Strategies and Developments 13.3.6. Innovent Biologics, Inc. 13.3.6.1. Company Overview 13.3.6.2. Product Portfolio 13.3.6.3. Financial Overview 13.3.6.4. Business Strategies and Developments 14. Appendix 14.1. Research Methodology 14.2. Report Assumptions 14.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
Persistence Market Research社の 医療・製薬・メディカルデバイス分野 での最新刊レポート
本レポートと同じKEY WORD（receptor）の最新刊レポート
よくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
